|
⚲
|
| Keyboard |
| Michael Gladstone | |
|---|---|
| Firm | Atlas Venture Life Science Advisors LLC |
| Address | 300 Technology Square 8th Floor Cambridge, MA 02139 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Atlas Venture Life Science Advisors LLC | |||||
| Atlas Venture Opportunity Fund III LP | 021-556589 | Executive Officer | 400.0 M of 400.0 M |
399.0 M | |
| Atlas Venture Fund XIV LP | 021-531177 | Executive Officer | 450.0 M of 450.0 M |
452.0 M | |
| Atlas Venture Fund XIII LP | 021-435762 | Executive Officer | 450.0 M of 450.0 M |
551.4 M | |
| Atlas Venture Opportunity Fund II LP | 021-415392 | Executive Officer | 300.0 M of 300.0 M |
287.4 M | |
| Atlas Venture Fund XII LP | 021-368325 | Executive Officer | 400.0 M of 400.0 M |
318.2 M | |
| Caldera Therapeutics Inc | 021-570654 | Director | 37.5 M of 37.5 M |
||
| Day One Biopharmaceuticals Holding Co LLC | 021-389508 | Director | 130.0 M of 130.0 M |
||
| Akriveia Therapeutics LLC | 021-304462 | Director | 3.0 M of 22.5 M |
||